BECTON DICKINSON AND CO (BDX) Stock Overview
NYSE:BDX - US0758871091 - Common Stock
BDX Key Statistics, Chart & Performance
The current stock price of BDX is 192.98 USD. In the past month the price increased by 9.42%. In the past year, price decreased by -20.39%.
BDX Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 27.07 | 230.89B | ||
| ISRG | INTUITIVE SURGICAL INC | 58.79 | 169.67B | ||
| BSX | BOSTON SCIENTIFIC CORP | 37.28 | 156.32B | ||
| SYK | STRYKER CORP | 30.46 | 149.64B | ||
| MDT | MEDTRONIC PLC | 16.78 | 119.05B | ||
| IDXX | IDEXX LABORATORIES INC | 53.88 | 51.77B | ||
| EW | EDWARDS LIFESCIENCES CORP | 31.65 | 47.75B | ||
| RMD | RESMED INC | 28.74 | 40.19B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 15.82 | 33.66B | ||
| DXCM | DEXCOM INC | 44.32 | 29.55B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 16.42 | 26.56B | ||
| STE | STERIS PLC | 25.69 | 24.14B |
Related stock screener links
About BDX
Company Profile
Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. The company is headquartered in Franklin Lakes, New Jersey and currently employs 74,000 full-time employees. The firm is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. Its BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. The BD Medical segment consists of various business units, including medication delivery solutions, medication management solutions, advanced monitoring, and pharmaceutical systems. Its BD Life Sciences segment provides products for the collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. Its BD Interventional segment provides vascular, urology, oncology and surgical specialty products.
Company Info
BECTON DICKINSON AND CO
One Becton Drive
Franklin Lakes NEW JERSEY 07417 US
CEO: Thomas E. Polen
Employees: 74000
Phone: 12018476800
BECTON DICKINSON AND CO / BDX FAQ
What is the stock price of BECTON DICKINSON AND CO today?
The current stock price of BDX is 192.98 USD. The price increased by 0.9% in the last trading session.
What is the ticker symbol for BECTON DICKINSON AND CO stock?
The exchange symbol of BECTON DICKINSON AND CO is BDX and it is listed on the New York Stock Exchange, Inc. exchange.
On which exchange is BDX stock listed?
BDX stock is listed on the New York Stock Exchange, Inc. exchange.
What is the price forecast or stock price prediction for BECTON DICKINSON AND CO stock?
21 analysts have analysed BDX and the average price target is 226.96 USD. This implies a price increase of 17.61% is expected in the next year compared to the current price of 192.98. Check the BECTON DICKINSON AND CO stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is BECTON DICKINSON AND CO worth?
BECTON DICKINSON AND CO (BDX) has a market capitalization of 55.31B USD. This makes BDX a Large Cap stock.
How many employees does BECTON DICKINSON AND CO have?
BECTON DICKINSON AND CO (BDX) currently has 74000 employees.
What are the support and resistance levels for BECTON DICKINSON AND CO (BDX) stock?
BECTON DICKINSON AND CO (BDX) has a support level at 175.33 and a resistance level at 195.69. Check the full technical report for a detailed analysis of BDX support and resistance levels.
Is BECTON DICKINSON AND CO (BDX) expected to grow?
The Revenue of BECTON DICKINSON AND CO (BDX) is expected to grow by 8.4% in the next year. Check the estimates tab for more information on the BDX EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy BECTON DICKINSON AND CO (BDX) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of BDX, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of BDX, evaluating the profitability, health, valuation and growth aspects
- BECTON DICKINSON AND CO (BDX) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- BECTON DICKINSON AND CO (BDX) Sales and EPS estimates to see what analysts future expectations are.
- BECTON DICKINSON AND CO (BDX) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- BECTON DICKINSON AND CO (BDX) Insider and Institutional Ownership to learn about the owners and their transactions.
- BECTON DICKINSON AND CO (BDX) Stock Chart to make your own analysis
- BECTON DICKINSON AND CO (BDX) Latest news and press-releases to stay up to date.
Does BECTON DICKINSON AND CO (BDX) stock pay dividends?
BECTON DICKINSON AND CO (BDX) has a dividend yield of 2.18%. The yearly dividend amount is currently 3.8. Check the full fundamental report for a detailed analysis of BDX dividend history, reliability and sustainability.
When does BECTON DICKINSON AND CO (BDX) report earnings?
BECTON DICKINSON AND CO (BDX) will report earnings on 2025-11-06, after the market close.
What is the Price/Earnings (PE) ratio of BECTON DICKINSON AND CO (BDX)?
The PE ratio for BECTON DICKINSON AND CO (BDX) is 13.52. This is based on the reported non-GAAP earnings per share of 14.27 and the current share price of 192.98 USD. Check the full fundamental report for a full analysis of the valuation metrics for BDX.
What is the Short Interest ratio of BECTON DICKINSON AND CO (BDX) stock?
The outstanding short interest for BECTON DICKINSON AND CO (BDX) is 1.92% of its float. Check the ownership tab for more information on the BDX short interest.
BDX Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to BDX. When comparing the yearly performance of all stocks, BDX is a bad performer in the overall market: 77.7% of all stocks are doing better.
BDX Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to BDX. While BDX belongs to the best of the industry regarding profitability, there are concerns on its financial health.
BDX Financial Highlights
Over the last trailing twelve months BDX reported a non-GAAP Earnings per Share(EPS) of 14.27. The EPS increased by 11.75% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 7.51% | ||
| ROA | 2.93% | ||
| ROE | 6.3% | ||
| Debt/Equity | 0.69 |
BDX Forecast & Estimates
21 analysts have analysed BDX and the average price target is 226.96 USD. This implies a price increase of 17.61% is expected in the next year compared to the current price of 192.98.
For the next year, analysts expect an EPS growth of 10.39% and a revenue growth 8.4% for BDX